NO-1886
CAS: 133208-93-2
Ref. 3D-IFA20893
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
- 4-[N-(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonic acid diethyl ester
- Diethyl [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]phosphonate
- Diethyl {4-[(4-Bromo-2-Cyanophenyl)Carbamoyl]Benzyl}Phosphonate
- Ibrolipim
- No-1886
- Opf-009
- Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester
NO-1886 is a novel small molecule that inhibits the activity of growth factor-β1 and is used to treat metabolic disorders, such as bowel disease. It has been shown to increase the expression of lipoprotein lipase in human serum and adipose tissue. NO-1886 also reduces hepatic steatosis and tubulointerstitial injury by inhibiting lipolysis, which prevents the release of fatty acids from adipose tissue into the blood stream. This drug is being developed for clinical trials for the treatment of atherosclerotic lesions.
Chemical properties
Technical inquiry about: 3D-IFA20893 NO-1886
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
